NeuroDerm (NDRM) Misses Q2 EPS by 12c

NeuroDerm (NASDAQ: NDRM) reported Q2 EPS of ($0.44), $0.12 worse than the analyst estimate of ($0.32).

As of June 30, 2016, the Company had cash and cash equivalents and short-term bank deposits totaling $89.8 million.

For earnings history and earnings-related data on NeuroDerm (NDRM) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor